dc.contributor.author | Millett, Piers | |
dc.contributor.author | Alexanian, Tessa | |
dc.contributor.author | Palmer, Megan J | |
dc.contributor.author | Evans, Sam Weiss | |
dc.contributor.author | Kuiken, Todd | |
dc.contributor.author | Oye, Kenneth | |
dc.date.accessioned | 2023-03-23T16:11:43Z | |
dc.date.available | 2023-03-23T16:11:43Z | |
dc.date.issued | 2022 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/148676 | |
dc.description.abstract | Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experiences and lessons are distilled into 6 key insights for future gene drive policy development in the United States: (1) gene drives deserve special attention because of their potential for widescale impact and remaining uncertainty about how to evaluate intergenerational and transboundary risks; (2) an adaptive risk management approach is logical for gene drives because of the rapidly changing technical environment; (3) review by individual technical experts is limited and may fail to incorporate other forms of expertise and, therefore, must be complemented with a range of alternative governance methods; (4) current laboratory biosafety and biosecurity review processes may not capture gene drive research or its components in practice even if they are covered theoretically; (5) risk management for research and development must incorporate discussions of values and broader implications of the work; and (6) a regular technology horizon scanning capacity is needed for the early identification of advances that could pose governance system challenges. | en_US |
dc.language.iso | en | |
dc.publisher | Mary Ann Liebert Inc | en_US |
dc.relation.isversionof | 10.1089/HS.2021.0157 | en_US |
dc.rights | Creative Commons Attribution 4.0 International license | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
dc.source | Mary Ann Liebert | en_US |
dc.title | iGEM and Gene Drives: A Case Study for Governance | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Millett, Piers, Alexanian, Tessa, Palmer, Megan J, Evans, Sam Weiss, Kuiken, Todd et al. 2022. "iGEM and Gene Drives: A Case Study for Governance." Health Security, 20 (1). | |
dc.contributor.department | Massachusetts Institute of Technology. Department of Political Science | en_US |
dc.relation.journal | Health Security | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2023-03-23T15:41:19Z | |
dspace.orderedauthors | Millett, P; Alexanian, T; Palmer, MJ; Evans, SW; Kuiken, T; Oye, K | en_US |
dspace.date.submission | 2023-03-23T15:41:21Z | |
mit.journal.volume | 20 | en_US |
mit.journal.issue | 1 | en_US |
mit.license | PUBLISHER_CC | |
mit.metadata.status | Authority Work and Publication Information Needed | en_US |